You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Nucala

Introducing Nucala® (mepolizumab)

A targeted anti-IL-5 add-on treatment for adults with severe refractory eosinophilic asthma.

Find out more

Prescribing information

 

How to use Ellipta video

Video: How to use the Ellipta inhaler

A useful step-by-step guide designed to help patients use their inhaler correctly.

Watch the video

 

syringe

Vaccines.co.uk update

Our vaccines ordering website has been redesigned and is now packed with new features - we are confident these changes will save you time and help you manage your GSK vaccines purchases more effectively.
 

Order now

Amoxil (amoxicillin) SPC and PIL updates

Please note that the Amoxil SPCs and PILs were updated on 2nd March 2016 in line with a European Harmonisation Process. Please see the Amoxil product page for further information.

View our products

View our products

Find information on our products including resources for patients.

Expert perspectives

Respiratory Knowledge base

Watch videos on everything from disease and patient management to research and development.


Find out more

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard .
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

Amoxil, Nucala and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies.